tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Biodexa Pharmaceuticals unveils ‘Serenta’ as name for upcoming Phase 3 FAP study
PremiumThe FlyBiodexa Pharmaceuticals unveils ‘Serenta’ as name for upcoming Phase 3 FAP study
1M ago
Biodexa Pharmaceuticals Announces Successful Passing of General Meeting Resolutions
Premium
Company Announcements
Biodexa Pharmaceuticals Announces Successful Passing of General Meeting Resolutions
2M ago
Biodexa Pharmaceuticals Initiates Phase 2 Study for Type 1 Diabetes Treatment
Premium
Company Announcements
Biodexa Pharmaceuticals Initiates Phase 2 Study for Type 1 Diabetes Treatment
2M ago
Biodexa Pharmaceuticals Plans Share Capital Reorganization and New Share Allotment
PremiumCompany AnnouncementsBiodexa Pharmaceuticals Plans Share Capital Reorganization and New Share Allotment
2M ago
Biodexa Pharmaceuticals Secures Additional $3M Grant for eRapa Phase 3 Program
Premium
Company Announcements
Biodexa Pharmaceuticals Secures Additional $3M Grant for eRapa Phase 3 Program
2M ago
Biodexa Pharmaceuticals announces award of additional $3M grant from CPRIT
Premium
The Fly
Biodexa Pharmaceuticals announces award of additional $3M grant from CPRIT
2M ago
Biodexa Pharmaceuticals Announces General Meeting for Strategic Share Resolutions
PremiumCompany AnnouncementsBiodexa Pharmaceuticals Announces General Meeting for Strategic Share Resolutions
3M ago
Biodexa Pharmaceuticals Reports 2024 Preliminary Results and 2025 Strategic Priorities
Premium
Company Announcements
Biodexa Pharmaceuticals Reports 2024 Preliminary Results and 2025 Strategic Priorities
4M ago
Biodexa reports preliminary FY24 EPS GBP (0.1)p vs GBP (2)p last year
Premium
The Fly
Biodexa reports preliminary FY24 EPS GBP (0.1)p vs GBP (2)p last year
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100